Chidamide
Cell-permeable. A new benzamide class of histone deacetylase (HDAC) inhibitor with marked anti-tumor activity. It increases histone H3 acetylation levels in LoVo and HT29 colon cancer cells at concentrations as low as 4 µM. Additionally, chidamide affects the activation of oncogenic signaling kinases by dose-dependently reducing phosphorylated Akt, mTOR, p70S6k, Raf, and Erk1/2 protein expression in colon cancer cells.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
24 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
![2,4,6-trihydroxy-3-{[2-methyl-5- (propan-2-yl) phenyl]methyl}-5- (3-methylbutanoyl) benzaldehyde](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
orb3170419-01 1 mg
2,4,6-trihydroxy-3-{[2-methyl-5- (propan-2-yl) phenyl]methyl}-5- (3-methylbutanoyl) benzaldehyde
Sign In for Pricing
View Details ![2,4,6-trihydroxy-3-{[2-methyl-5- (propan-2-yl) phenyl]methyl}-5- (3-methylbutanoyl) benzaldehyde](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
orb3170419-02 2 mg
2,4,6-trihydroxy-3-{[2-methyl-5- (propan-2-yl) phenyl]methyl}-5- (3-methylbutanoyl) benzaldehyde
Sign In for Pricing
View Details ![2,4,6-trihydroxy-3-{[2-methyl-5- (propan-2-yl) phenyl]methyl}-5- (3-methylbutanoyl) benzaldehyde](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
orb3170419-03 3 mg
2,4,6-trihydroxy-3-{[2-methyl-5- (propan-2-yl) phenyl]methyl}-5- (3-methylbutanoyl) benzaldehyde
Sign In for Pricing
View Details orb3170419-04 4 mg
2,4,6-trihydroxy-3-{[2-methyl-5- (propan-2-yl) phenyl]methyl}-5- (3-methylbutanoyl) benzaldehyde
Sign In for Pricing
View Details ![2,4,6-trihydroxy-3-{[2-methyl-5- (propan-2-yl) phenyl]methyl}-5- (3-methylbutanoyl) benzaldehyde](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
orb3170419-05 5 mg
2,4,6-trihydroxy-3-{[2-methyl-5- (propan-2-yl) phenyl]methyl}-5- (3-methylbutanoyl) benzaldehyde
Sign In for Pricing
View Details